In last trading session, Metagenomi Inc (NASDAQ:MGX) saw 0.59 million shares changing hands with its beta currently measuring -0.36. Company’s recent per share price level of $1.41 trading at $0.15 or 11.90% at ring of the bell on the day assigns it a market valuation of $52.71M. That closing price of MGX’s stock is at a discount of -675.89% from its 52-week high price of $10.94 and is indicating a premium of 11.35% from its 52-week low price of $1.25. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.49 million shares which gives us an average trading volume of 907.79K if we extend that period to 3-months.
For Metagenomi Inc (MGX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.33. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.51 in the current quarter.
Metagenomi Inc (NASDAQ:MGX) trade information
Upright in the green during last session for gaining 11.90%, in the last five days MGX remained trading in the red while hitting it’s week-highest on Monday, 03/31/25 when the stock touched $1.41 price level, adding 4.73% to its value on the day. Metagenomi Inc’s shares saw a change of -60.94% in year-to-date performance and have moved -4.73% in past 5-day. Metagenomi Inc (NASDAQ:MGX) showed a performance of -27.32% in past 30-days. Number of shares sold short was 2.64 million shares which calculate 6.21 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 14.5 to the stock, which implies a rise of 90.28% to its current value. Analysts have been projecting 7 as a low price target for the stock while placing it at a high target of 22. It follows that stock’s current price would drop -396.45% in reaching the projected high whereas dropping to the targeted low would mean a loss of -396.45% for stock’s current value.
Metagenomi Inc (MGX) estimates and forecasts
This year revenue growth is estimated to fall -38.98% from the last financial year’s standing.
5 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 7.96M for the same. And 5 analysts are in estimates of company making revenue of 8.52M in the next quarter. Company posted 11.16M and 20.01M of sales in current and next quarters respectively a year earlier.
In 2025, company’s earnings growth rate is likely to be around -0.83% while estimates for its earnings growth in next 5 years are of -16.92%.
Metagenomi Inc (NASDAQ:MGX)’s Major holders
Insiders are in possession of 28.83% of company’s total shares while institution are holding 28.78 percent of that, with stock having share float percentage of 40.44%. Investors also watch the number of corporate investors in a company very closely, which is 28.78% institutions for Metagenomi Inc that are currently holding shares of the company. NOVO HOLDINGS A/S is the top institutional holder at MGX for having 1.8 million shares of worth $7.34 million. And as of 2024-06-30, it was holding 4.9146 of the company’s outstanding shares.
The second largest institutional holder is RA CAPITAL MANAGEMENT, L.P., which was holding about 1.48 million shares on 2024-06-30. The number of shares represents firm’s hold over 4.0348 of outstanding shares, having a total worth of $6.03 million.
On the other hand, iShares Trust-iShares Russell 2000 ETF and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Feb 28, 2025 , the former fund manager was holding 673.14 shares of worth $0.95 million or 1.80% of the total outstanding shares. The later fund manager was in possession of 484.25 shares on Dec 31, 2024 , making its stake of worth around $0.68 million in the company or a holder of 1.30% of company’s stock.
